Diseases, Conditions, Syndromes

Candidate tuberculosis vaccine in phase II/III trial

Tuberculosis remains the most deadly infectious diseases in the world. In particular, the growing number of multiresistant microbes is a cause of great concern to doctors and healthcare policymakers. At least a dozen candidate ...

Diseases, Conditions, Syndromes

Possible breakthrough in tuberculosis research on the horizon

"New weapon in fight against the deadliest disease! Medicine can be used to treat existing illness and prevent reoccurrence." These headlines were published 125 years ago and shook up not only the world of science and medicine, ...

Medications

Serum Institute of India acquires rights to German TB vaccine

Hopes are high for a new and improved tuberculosis vaccine: Serum Institute of India is planning on taking a promising vaccine - originally developed in Germany - and introducing it into the clinical setting. Studies have ...

page 4 from 7